US 8895579
Heterotricyclic AMPA receptor antagonists for treatment of epilepsy, pain, and other neurological disorders and diseases
granted A61KA61K31/407A61K31/437
Quick answer
US patent 8895579 (Heterotricyclic AMPA receptor antagonists for treatment of epilepsy, pain, and other neurological disorders and diseases) held by Northwestern University expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/407, A61K31/437, A61P, A61P25/00